New gene therapy shows promise in reversing vision loss or blindness in patients with rare disease – Baylor College of Medicine News (press release)
Baylor College of Medicine News (press release) |
New gene therapy shows promise in reversing vision loss or blindness in patients with rare disease
Baylor College of Medicine News (press release) A new FDA-approved gene therapy treatment for patients with an inherited form of vision loss is now available at Baylor College of Medicine. The therapy, LUXTURNA™ (voretigene neparvovec-rzyl), was developed by Spark Therapeutics. Baylor is one of … |
